Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glomerulosclerosis, Focal Segmental | 4 | 2023 | 43 | 1.920 |
Why?
|
Kidney Transplantation | 8 | 2022 | 839 | 1.810 |
Why?
|
Blood Component Removal | 2 | 2022 | 19 | 1.590 |
Why?
|
Nephrotic Syndrome | 2 | 2022 | 61 | 1.520 |
Why?
|
Acute Kidney Injury | 6 | 2022 | 232 | 1.490 |
Why?
|
Graft Rejection | 6 | 2021 | 458 | 1.220 |
Why?
|
Kidney Diseases | 3 | 2022 | 307 | 0.930 |
Why?
|
Renal Insufficiency | 4 | 2022 | 121 | 0.920 |
Why?
|
Hydronephrosis | 1 | 2022 | 12 | 0.820 |
Why?
|
Glomerulonephritis, IGA | 2 | 2019 | 12 | 0.820 |
Why?
|
Urinary Tract | 1 | 2022 | 10 | 0.820 |
Why?
|
Immunosuppressive Agents | 5 | 2019 | 514 | 0.800 |
Why?
|
Child | 22 | 2022 | 6405 | 0.770 |
Why?
|
Kidney Tubules, Proximal | 5 | 2012 | 81 | 0.740 |
Why?
|
Sodium-Hydrogen Exchangers | 4 | 2012 | 43 | 0.670 |
Why?
|
Fish Oils | 1 | 2019 | 21 | 0.660 |
Why?
|
Kidney | 4 | 2022 | 945 | 0.610 |
Why?
|
Referral and Consultation | 1 | 2020 | 383 | 0.610 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 186 | 0.590 |
Why?
|
Aftercare | 1 | 2018 | 114 | 0.570 |
Why?
|
Infant, Newborn | 10 | 2022 | 2455 | 0.560 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 33 | 0.520 |
Why?
|
Opportunistic Infections | 1 | 2015 | 33 | 0.520 |
Why?
|
Dexamethasone | 2 | 2012 | 150 | 0.480 |
Why?
|
Practice Patterns, Physicians' | 1 | 2018 | 504 | 0.440 |
Why?
|
Retrospective Studies | 15 | 2022 | 7277 | 0.430 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 2019 | 123 | 0.420 |
Why?
|
Lymphoproliferative Disorders | 1 | 2012 | 37 | 0.410 |
Why?
|
Central Nervous System Diseases | 1 | 2012 | 40 | 0.410 |
Why?
|
Methotrexate | 1 | 2012 | 91 | 0.400 |
Why?
|
Immunologic Factors | 1 | 2012 | 87 | 0.390 |
Why?
|
Acidosis | 2 | 2012 | 31 | 0.390 |
Why?
|
Nephrology | 2 | 2022 | 43 | 0.390 |
Why?
|
Humans | 33 | 2023 | 68618 | 0.380 |
Why?
|
Iatrogenic Disease | 1 | 2011 | 36 | 0.380 |
Why?
|
Ductus Arteriosus, Patent | 2 | 2022 | 38 | 0.380 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 649 | 0.360 |
Why?
|
Adolescent | 13 | 2022 | 8912 | 0.350 |
Why?
|
Biopsy | 5 | 2019 | 540 | 0.340 |
Why?
|
Infant | 11 | 2022 | 2891 | 0.340 |
Why?
|
Treatment Outcome | 10 | 2020 | 7029 | 0.320 |
Why?
|
Male | 21 | 2022 | 37321 | 0.310 |
Why?
|
Renal Replacement Therapy | 2 | 2017 | 40 | 0.290 |
Why?
|
Female | 21 | 2022 | 38074 | 0.290 |
Why?
|
Fetus | 2 | 2022 | 157 | 0.280 |
Why?
|
Diarrhea | 2 | 2020 | 63 | 0.280 |
Why?
|
Recurrence | 2 | 2022 | 948 | 0.270 |
Why?
|
Child, Preschool | 8 | 2022 | 3187 | 0.260 |
Why?
|
Hypertension | 3 | 2022 | 1535 | 0.260 |
Why?
|
Intensive Care Units, Neonatal | 3 | 2021 | 113 | 0.250 |
Why?
|
Bortezomib | 2 | 2017 | 45 | 0.250 |
Why?
|
Rituximab | 3 | 2017 | 61 | 0.240 |
Why?
|
Creatinine | 2 | 2022 | 243 | 0.220 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2022 | 15 | 0.210 |
Why?
|
Health Information Systems | 1 | 2022 | 18 | 0.210 |
Why?
|
Dilatation, Pathologic | 1 | 2022 | 58 | 0.200 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2022 | 89 | 0.200 |
Why?
|
Dilatation | 1 | 2022 | 58 | 0.200 |
Why?
|
Pseudohypoaldosteronism | 1 | 2021 | 4 | 0.200 |
Why?
|
Sclerosis | 1 | 2021 | 32 | 0.200 |
Why?
|
Hyponatremia | 1 | 2021 | 20 | 0.190 |
Why?
|
Remission Induction | 1 | 2021 | 111 | 0.190 |
Why?
|
Microvilli | 5 | 2012 | 22 | 0.190 |
Why?
|
Drug Resistance | 1 | 2021 | 223 | 0.180 |
Why?
|
Nephrectomy | 1 | 2021 | 103 | 0.180 |
Why?
|
Critical Illness | 2 | 2022 | 191 | 0.180 |
Why?
|
Lupus Nephritis | 1 | 2022 | 193 | 0.180 |
Why?
|
Fibroblast Growth Factors | 2 | 2011 | 51 | 0.180 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2021 | 138 | 0.170 |
Why?
|
Guidelines as Topic | 1 | 2020 | 123 | 0.170 |
Why?
|
Lipoproteins, LDL | 1 | 2022 | 343 | 0.170 |
Why?
|
Incidence | 3 | 2021 | 1603 | 0.170 |
Why?
|
Follow-Up Studies | 4 | 2019 | 3259 | 0.170 |
Why?
|
Heart Failure | 2 | 2019 | 1180 | 0.170 |
Why?
|
Nephrosis, Lipoid | 1 | 2018 | 9 | 0.160 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2018 | 8 | 0.160 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 1140 | 0.160 |
Why?
|
Healthcare Disparities | 1 | 2022 | 378 | 0.160 |
Why?
|
Albuminuria | 1 | 2019 | 171 | 0.160 |
Why?
|
Patient Acceptance of Health Care | 1 | 2022 | 468 | 0.150 |
Why?
|
Pregnancy | 2 | 2022 | 2334 | 0.150 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2012 | 618 | 0.150 |
Why?
|
Parenteral Nutrition | 1 | 2017 | 39 | 0.150 |
Why?
|
Immunogenicity, Vaccine | 1 | 2017 | 8 | 0.150 |
Why?
|
Hepatitis B Vaccines | 1 | 2017 | 11 | 0.150 |
Why?
|
Sodium-Hydrogen Exchanger 3 | 3 | 2012 | 6 | 0.140 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2017 | 5 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2017 | 52 | 0.140 |
Why?
|
Hepatitis | 1 | 2017 | 25 | 0.140 |
Why?
|
Pediatrics | 1 | 2020 | 341 | 0.140 |
Why?
|
Hepatitis B | 1 | 2017 | 42 | 0.140 |
Why?
|
Risk Factors | 5 | 2023 | 5731 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 161 | 0.140 |
Why?
|
Peritoneal Dialysis | 1 | 2017 | 30 | 0.140 |
Why?
|
Echocardiography | 1 | 2019 | 515 | 0.140 |
Why?
|
Hemodynamics | 1 | 2019 | 705 | 0.140 |
Why?
|
Models, Theoretical | 1 | 2019 | 384 | 0.140 |
Why?
|
Quality Improvement | 1 | 2020 | 413 | 0.140 |
Why?
|
Patient Safety | 1 | 2018 | 202 | 0.130 |
Why?
|
Renal Dialysis | 1 | 2017 | 174 | 0.130 |
Why?
|
Antibodies | 1 | 2017 | 241 | 0.130 |
Why?
|
Computer Simulation | 1 | 2019 | 706 | 0.130 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 365 | 0.130 |
Why?
|
Vaccination | 1 | 2017 | 189 | 0.130 |
Why?
|
Anemia, Sickle Cell | 1 | 2019 | 364 | 0.130 |
Why?
|
Prognosis | 3 | 2018 | 2093 | 0.130 |
Why?
|
ROC Curve | 1 | 2015 | 392 | 0.120 |
Why?
|
B-Lymphocytes | 2 | 2017 | 329 | 0.120 |
Why?
|
Bicarbonates | 2 | 2012 | 21 | 0.120 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 4 | 2 | 2011 | 2 | 0.120 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2011 | 6 | 0.120 |
Why?
|
Methylprednisolone Hemisuccinate | 1 | 2013 | 3 | 0.110 |
Why?
|
Midwestern United States | 3 | 2019 | 36 | 0.110 |
Why?
|
Heart Transplantation | 1 | 2017 | 328 | 0.110 |
Why?
|
Plasma Exchange | 1 | 2013 | 18 | 0.110 |
Why?
|
Calcitriol | 2 | 2011 | 106 | 0.110 |
Why?
|
Boronic Acids | 1 | 2013 | 40 | 0.110 |
Why?
|
Pyrazines | 1 | 2013 | 46 | 0.110 |
Why?
|
HLA Antigens | 1 | 2013 | 82 | 0.110 |
Why?
|
Risk Assessment | 2 | 2018 | 2007 | 0.110 |
Why?
|
Kidney Calculi | 1 | 2013 | 19 | 0.110 |
Why?
|
Hypotension | 1 | 2013 | 74 | 0.110 |
Why?
|
Algorithms | 2 | 2015 | 1196 | 0.110 |
Why?
|
Fructose | 1 | 2013 | 51 | 0.110 |
Why?
|
Infusions, Intraventricular | 1 | 2012 | 8 | 0.100 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 30 | 0.100 |
Why?
|
Longitudinal Studies | 1 | 2015 | 1054 | 0.100 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2012 | 24 | 0.100 |
Why?
|
RNA, Messenger | 3 | 2011 | 1664 | 0.100 |
Why?
|
Fatal Outcome | 1 | 2012 | 164 | 0.100 |
Why?
|
Medication Adherence | 1 | 2015 | 335 | 0.100 |
Why?
|
Blood Pressure | 4 | 2022 | 1451 | 0.100 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 1753 | 0.100 |
Why?
|
Sodium | 1 | 2011 | 161 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2013 | 223 | 0.090 |
Why?
|
Time Factors | 3 | 2019 | 4655 | 0.090 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 208 | 0.090 |
Why?
|
Vancomycin | 1 | 2011 | 60 | 0.090 |
Why?
|
Diet, Protein-Restricted | 1 | 2010 | 4 | 0.090 |
Why?
|
Aminoglycosides | 1 | 2011 | 54 | 0.090 |
Why?
|
Amiloride | 1 | 2010 | 22 | 0.090 |
Why?
|
Patient Compliance | 1 | 2013 | 402 | 0.090 |
Why?
|
Graft Survival | 1 | 2013 | 465 | 0.090 |
Why?
|
Young Adult | 5 | 2022 | 5717 | 0.090 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2011 | 155 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 202 | 0.090 |
Why?
|
Seizures | 1 | 2012 | 279 | 0.090 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2009 | 1 | 0.090 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2009 | 1 | 0.090 |
Why?
|
Adult | 6 | 2022 | 21403 | 0.090 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2009 | 11 | 0.090 |
Why?
|
Hypophosphatemia | 1 | 2009 | 6 | 0.080 |
Why?
|
United States | 2 | 2021 | 7367 | 0.080 |
Why?
|
Animals, Newborn | 1 | 2010 | 396 | 0.080 |
Why?
|
Phosphorus | 1 | 2009 | 64 | 0.080 |
Why?
|
Anti-Infective Agents | 1 | 2011 | 166 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2010 | 189 | 0.080 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2010 | 154 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 240 | 0.080 |
Why?
|
Mice | 5 | 2012 | 8474 | 0.080 |
Why?
|
Epilepsy | 1 | 2013 | 336 | 0.080 |
Why?
|
Rats | 3 | 2011 | 5300 | 0.080 |
Why?
|
Contrast Media | 1 | 2011 | 595 | 0.070 |
Why?
|
Glomerular Filtration Rate | 2 | 2019 | 274 | 0.070 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 2791 | 0.070 |
Why?
|
Prospective Studies | 3 | 2022 | 3705 | 0.070 |
Why?
|
Animals | 7 | 2012 | 20881 | 0.070 |
Why?
|
Disease Progression | 2 | 2019 | 1038 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 1293 | 0.060 |
Why?
|
Postoperative Complications | 1 | 2012 | 1615 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 1465 | 0.060 |
Why?
|
Intestinal Mucosa | 2 | 2017 | 219 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 2223 | 0.050 |
Why?
|
Apolipoprotein L1 | 1 | 2023 | 16 | 0.050 |
Why?
|
Age Factors | 2 | 2018 | 1864 | 0.050 |
Why?
|
Apolipoproteins | 1 | 2023 | 51 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2010 | 2550 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2012 | 1692 | 0.050 |
Why?
|
Social Class | 1 | 2022 | 127 | 0.050 |
Why?
|
Pediatricians | 1 | 2021 | 9 | 0.050 |
Why?
|
Blood Pressure Determination | 1 | 2022 | 152 | 0.050 |
Why?
|
Failure to Thrive | 1 | 2021 | 17 | 0.050 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 39 | 0.050 |
Why?
|
Kidney Glomerulus | 1 | 2022 | 155 | 0.050 |
Why?
|
Allografts | 1 | 2021 | 63 | 0.050 |
Why?
|
Enteropathogenic Escherichia coli | 1 | 2020 | 6 | 0.050 |
Why?
|
Cryptosporidiosis | 1 | 2020 | 7 | 0.050 |
Why?
|
Cryptosporidium | 1 | 2020 | 9 | 0.050 |
Why?
|
Sapovirus | 1 | 2020 | 7 | 0.050 |
Why?
|
Genotype | 1 | 2023 | 786 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2022 | 652 | 0.040 |
Why?
|
Feces | 1 | 2020 | 88 | 0.040 |
Why?
|
Norovirus | 1 | 2020 | 31 | 0.040 |
Why?
|
Reoperation | 1 | 2021 | 467 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 492 | 0.040 |
Why?
|
Organ Transplantation | 1 | 2020 | 110 | 0.040 |
Why?
|
Birth Weight | 1 | 2019 | 186 | 0.040 |
Why?
|
Gestational Age | 1 | 2019 | 389 | 0.040 |
Why?
|
Glomerulonephritis | 1 | 2018 | 77 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2018 | 191 | 0.040 |
Why?
|
Body Mass Index | 1 | 2021 | 867 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 245 | 0.040 |
Why?
|
Dietary Proteins | 1 | 2017 | 51 | 0.040 |
Why?
|
Infant Mortality | 1 | 2017 | 59 | 0.040 |
Why?
|
Seroconversion | 1 | 2017 | 3 | 0.040 |
Why?
|
Hepatitis B Antibodies | 1 | 2017 | 8 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2017 | 17 | 0.040 |
Why?
|
Thymectomy | 1 | 2017 | 11 | 0.040 |
Why?
|
Linear Models | 1 | 2018 | 521 | 0.040 |
Why?
|
Cohort Studies | 1 | 2023 | 2358 | 0.040 |
Why?
|
Survival Analysis | 1 | 2018 | 714 | 0.040 |
Why?
|
Immune System | 1 | 2017 | 63 | 0.030 |
Why?
|
Nutritional Status | 1 | 2017 | 112 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2018 | 281 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 94 | 0.030 |
Why?
|
Length of Stay | 1 | 2019 | 780 | 0.030 |
Why?
|
Sirolimus | 1 | 2017 | 118 | 0.030 |
Why?
|
Primary Health Care | 1 | 2021 | 703 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2018 | 1174 | 0.030 |
Why?
|
Logistic Models | 1 | 2019 | 1420 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2018 | 1046 | 0.030 |
Why?
|
Tacrolimus | 1 | 2017 | 127 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 536 | 0.030 |
Why?
|
Sex Factors | 1 | 2018 | 1266 | 0.030 |
Why?
|
Heart | 1 | 2019 | 850 | 0.030 |
Why?
|
Lung | 1 | 2019 | 849 | 0.030 |
Why?
|
Up-Regulation | 1 | 2017 | 682 | 0.030 |
Why?
|
Transplant Recipients | 1 | 2015 | 109 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2019 | 2077 | 0.030 |
Why?
|
Urban Population | 1 | 2015 | 255 | 0.030 |
Why?
|
Hypercalciuria | 1 | 2013 | 1 | 0.030 |
Why?
|
Alkalies | 1 | 2013 | 6 | 0.030 |
Why?
|
Citric Acid | 1 | 2013 | 16 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2018 | 1851 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2017 | 597 | 0.030 |
Why?
|
Quality of Life | 1 | 2020 | 1515 | 0.030 |
Why?
|
Models, Animal | 1 | 2012 | 252 | 0.020 |
Why?
|
Biomarkers | 1 | 2017 | 1593 | 0.020 |
Why?
|
Phosphates | 1 | 2011 | 72 | 0.020 |
Why?
|
Homeostasis | 1 | 2012 | 291 | 0.020 |
Why?
|
South Carolina | 1 | 2017 | 2752 | 0.020 |
Why?
|
Metyrapone | 1 | 2010 | 3 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2015 | 581 | 0.020 |
Why?
|
Base Sequence | 1 | 2011 | 1015 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2009 | 89 | 0.020 |
Why?
|
Hospitalization | 1 | 2015 | 978 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 1447 | 0.020 |
Why?
|
Calcium | 1 | 2013 | 929 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2009 | 117 | 0.020 |
Why?
|
Prevalence | 1 | 2013 | 1619 | 0.020 |
Why?
|
Down-Regulation | 1 | 2009 | 447 | 0.020 |
Why?
|
Cell Line | 1 | 2011 | 1752 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2009 | 742 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2011 | 2673 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 2083 | 0.020 |
Why?
|
Middle Aged | 1 | 2018 | 21147 | 0.010 |
Why?
|